Cargando…

Temperature Management With Paracetamol in Acute Stroke Patients: Evidence From Randomized Controlled Trials

Whether or not paracetamol can improve functional outcomes in patients with acute stroke has been examined in several clinical trials. The inconsistent results of these trials have caused great controversy regarding the need for further studies. In the present meta-analysis, we have aimed to address...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Huawei, Qian, Hui, Gu, Zhiwei, Wang, Majun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255928/
https://www.ncbi.nlm.nih.gov/pubmed/30515128
http://dx.doi.org/10.3389/fneur.2018.00917
_version_ 1783374049909407744
author Chen, Huawei
Qian, Hui
Gu, Zhiwei
Wang, Majun
author_facet Chen, Huawei
Qian, Hui
Gu, Zhiwei
Wang, Majun
author_sort Chen, Huawei
collection PubMed
description Whether or not paracetamol can improve functional outcomes in patients with acute stroke has been examined in several clinical trials. The inconsistent results of these trials have caused great controversy regarding the need for further studies. In the present meta-analysis, we have aimed to address this controversy. The main databases (Medline, Embase, and Cochrane Library) were searched for randomized controlled trials involving the use of paracetamol in acute stroke patients. Pooled relative risks (RRs) or mean differences (MDs) and 95% confidence intervals (CIs) were calculated using a random-effects model. A total of 1,836 patients were pooled from four phase II and two phase III trials. The use of paracetamol resulted in a significant reduction in body temperature after 24 h (MD, −0.21; 95% CI, −0.28 to −0.13; P < 0.001) and mortality rate after 7–14 days (RR, 0.62; 95% CI, 0.41–0.93; P = 0.02) when compared with the placebo group; however, no effect of paracetamol was observed in the modified Rankin Scale score (RR, 1.07; 95% CI, 0.91–1.27; P = 0.40) or Barthel Index score (RR, 0.98; 95% CI, 0.91–1.06; P = 0.63) at 30 or 90 days. No significant differences were observed with respect to serious adverse events between the paracetamol and the placebo groups (P > 0.05). Subgroup analyses were performed to detect the source of the heterogeneity, which showed that ischemic stroke, serious condition at baseline, and late time-to-treatment had adverse impacts on the effect of paracetamol post stroke. In conclusion, temperature management with paracetamol in acute stroke patients is safe. Although paracetamol reduced the mortality rate in the early stage of stroke, it did not appear to affect long-term mortality and functional recovery. It should be noted that this conclusion is based on the results from studies of poor quality. A large clinical trial with a focus on early treatment of patients with acute stroke is warranted.
format Online
Article
Text
id pubmed-6255928
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62559282018-12-04 Temperature Management With Paracetamol in Acute Stroke Patients: Evidence From Randomized Controlled Trials Chen, Huawei Qian, Hui Gu, Zhiwei Wang, Majun Front Neurol Neurology Whether or not paracetamol can improve functional outcomes in patients with acute stroke has been examined in several clinical trials. The inconsistent results of these trials have caused great controversy regarding the need for further studies. In the present meta-analysis, we have aimed to address this controversy. The main databases (Medline, Embase, and Cochrane Library) were searched for randomized controlled trials involving the use of paracetamol in acute stroke patients. Pooled relative risks (RRs) or mean differences (MDs) and 95% confidence intervals (CIs) were calculated using a random-effects model. A total of 1,836 patients were pooled from four phase II and two phase III trials. The use of paracetamol resulted in a significant reduction in body temperature after 24 h (MD, −0.21; 95% CI, −0.28 to −0.13; P < 0.001) and mortality rate after 7–14 days (RR, 0.62; 95% CI, 0.41–0.93; P = 0.02) when compared with the placebo group; however, no effect of paracetamol was observed in the modified Rankin Scale score (RR, 1.07; 95% CI, 0.91–1.27; P = 0.40) or Barthel Index score (RR, 0.98; 95% CI, 0.91–1.06; P = 0.63) at 30 or 90 days. No significant differences were observed with respect to serious adverse events between the paracetamol and the placebo groups (P > 0.05). Subgroup analyses were performed to detect the source of the heterogeneity, which showed that ischemic stroke, serious condition at baseline, and late time-to-treatment had adverse impacts on the effect of paracetamol post stroke. In conclusion, temperature management with paracetamol in acute stroke patients is safe. Although paracetamol reduced the mortality rate in the early stage of stroke, it did not appear to affect long-term mortality and functional recovery. It should be noted that this conclusion is based on the results from studies of poor quality. A large clinical trial with a focus on early treatment of patients with acute stroke is warranted. Frontiers Media S.A. 2018-11-20 /pmc/articles/PMC6255928/ /pubmed/30515128 http://dx.doi.org/10.3389/fneur.2018.00917 Text en Copyright © 2018 Chen, Qian, Gu and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Chen, Huawei
Qian, Hui
Gu, Zhiwei
Wang, Majun
Temperature Management With Paracetamol in Acute Stroke Patients: Evidence From Randomized Controlled Trials
title Temperature Management With Paracetamol in Acute Stroke Patients: Evidence From Randomized Controlled Trials
title_full Temperature Management With Paracetamol in Acute Stroke Patients: Evidence From Randomized Controlled Trials
title_fullStr Temperature Management With Paracetamol in Acute Stroke Patients: Evidence From Randomized Controlled Trials
title_full_unstemmed Temperature Management With Paracetamol in Acute Stroke Patients: Evidence From Randomized Controlled Trials
title_short Temperature Management With Paracetamol in Acute Stroke Patients: Evidence From Randomized Controlled Trials
title_sort temperature management with paracetamol in acute stroke patients: evidence from randomized controlled trials
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255928/
https://www.ncbi.nlm.nih.gov/pubmed/30515128
http://dx.doi.org/10.3389/fneur.2018.00917
work_keys_str_mv AT chenhuawei temperaturemanagementwithparacetamolinacutestrokepatientsevidencefromrandomizedcontrolledtrials
AT qianhui temperaturemanagementwithparacetamolinacutestrokepatientsevidencefromrandomizedcontrolledtrials
AT guzhiwei temperaturemanagementwithparacetamolinacutestrokepatientsevidencefromrandomizedcontrolledtrials
AT wangmajun temperaturemanagementwithparacetamolinacutestrokepatientsevidencefromrandomizedcontrolledtrials